Join Ken Mulvany, Executive Chairman at BenevolentAI for a panel discussion on “Vision of the future” at WuXi Global Forum 2019.
The 2019 WuXi Global Forum during the J.P. Morgan Healthcare Conference will bring together global leaders to promote new thinking on a global stage as we strive to provide transformative models and solutions for patients. During this captivating forum, thought leaders will discuss the rapid advances and changes impacting innovation, from the most disruptive therapeutic interventions to artificial intelligence to the evolving global regulatory landscape.
Serial entrepreneur, investor and healthcare and technology veteran with more than 20 years of business leadership experience. He is currently a director of BenevolentAI, a technology company he founded, which is developing and using Artificial Intelligence to change the way knowledge is created and applied in Life Sciences. He was previously CEO of Proximagen, a UK-based biotech company committed to delivering novel drugs and innovative new treatments for central nervous system (CNS) disorders.
Read Ken’s latest blog “Using AI to unlock the world’s most complex operating system - the human body”